Page last updated: 2024-08-21

nitroblue tetrazolium and sirolimus

nitroblue tetrazolium has been researched along with sirolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gery, S; Ikezoe, T; Koeffler, HP; Nishioka, C; Yang, J; Yokoyama, A	1

Other Studies

1 other study(ies) available for nitroblue tetrazolium and sirolimus

Article	Year
Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells. International journal of cancer, 2009, Oct-01, Volume: 125, Issue:7 Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; CCAAT-Enhancer-Binding Proteins; CD11b Antigen; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Drug Synergism; Everolimus; Female; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred BALB C; Mice, Nude; Multiprotein Complexes; Neoplasm Proteins; Nitroblue Tetrazolium; Proteins; Proto-Oncogene Proteins c-myc; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Transplantation, Heterologous; Tretinoin; Tumor Stem Cell Assay; Up-Regulation	2009

Article

Year

Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.

International journal of cancer, 2009, Oct-01, Volume: 125, Issue:7

Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; CCAAT-Enhancer-Binding Proteins; CD11b Antigen; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Drug Synergism; Everolimus; Female; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred BALB C; Mice, Nude; Multiprotein Complexes; Neoplasm Proteins; Nitroblue Tetrazolium; Proteins; Proto-Oncogene Proteins c-myc; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Transplantation, Heterologous; Tretinoin; Tumor Stem Cell Assay; Up-Regulation

2009